Current trends in the surgical treatment of esophageal and cardia adenocarcinoma

A. Peracchia, L. Bonavina, A. Via, R. Incarbone

Research output: Contribution to journalArticlepeer-review


Since adenocarcinoma of the esophagus and cardia is increasing at an alarming rate, major efforts are currently oriented to identify patients who may benefit from extensive resection. Between November 1992 and May 1998, 218 patients with histologically proven adenocarcinoma of the distal esophagus or cardia were referred to our Department. In six patients (10.2%) with Barrett's adenocarcinoma, cancer was discovered during endoscopic surveillance program for Barrett's metaplasia. Overall, one hundred-forty- seven patients (67%) underwent resection. Fifty-one underwent an extended mediastinal lymphadenectomy. Median cumulative survival was 25.9±3.1 months in patients undergoing resection, and 7±1.3 months in patients having palliation (p

Original languageEnglish
Pages (from-to)289-294
Number of pages6
JournalJournal of Experimental and Clinical Cancer Research
Issue number3
Publication statusPublished - Sep 1999


  • Adenocarcinoma
  • Barrett's metaplasia
  • Cardia
  • Esophagus
  • Lymphadenectomy
  • Micrometastases
  • Neoadjuvant chemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Current trends in the surgical treatment of esophageal and cardia adenocarcinoma'. Together they form a unique fingerprint.

Cite this